Den gennemsnitlige pulmonale vaskulære modstand var signifikant reduceret i bosentangruppen (med en overvejende virkning observeret i subgruppen af patienter med tovejs intrakardiel shunt).
The mean pulmonary vascular resistance was significantly reduced in the bosentan group (with a predominant effect observed in the subgroup of patients with bidirectional intracardiac shunt).